Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

STMicroelectronics N.V. STM

Growth Flags show if company had growth for consecutive years

Analyst’s Commentary of STMicroelectronics N.V. (STM) Performance

STMicroelectronics N.V. (STM), a leading European semiconductor firm with a strong foothold in automotive, industrial, and consumer electronics chips, has navigated a volatile decade marked by cyclical booms and busts in the global chip industry. From the COVID-19 induced supply chain disruptions that fueled explosive growth in 2021-2023 to the subsequent inventory overhang and softening demand in 2024, STM’s fundamentals reflect the broader semiconductor sector’s rollercoaster ride. Revenue surged from $6.97 billion in 2016 to a peak of $17.29 billion in 2023—a staggering 148% increase over seven years—before contracting 23% to $13.27 billion in 2024. This trajectory mirrors stock price movements, with yearly highs climbing from $11.45 in 2016 to over $55 in 2023, only to retreat amid recent pressures. As we dissect the data, correlations emerge between robust profitability during peak demand, aggressive capex investments, and now a cautious outlook amid macroeconomic headwinds like geopolitical tensions and shifting EV adoption rates.

Historical Growth and Peak Performance

STM’s ascent from 2016 to 2023 was nothing short of remarkable, driven by tailwinds from the global chip shortage and surging demand for auto and industrial semiconductors. Revenue per employee, a key productivity metric, more than doubled from €160,373 in 2016 to €336,808 in 2023 (110% growth), underscoring operational efficiency gains amid workforce expansion from 43,480 to 51,323 employees. This efficiency fueled EBT margins expanding from a modest 2.88% to 27.55% (857% relative improvement), highlighting how scale and pricing power translated into profitability—crucial for a capital-intensive industry where margins signal competitive moats against rivals like Infineon or NXP.

Net income followed suit, rocketing from $170 million in 2016 to $4.22 billion in 2023 (2,382% cumulative growth), with ROE peaking at 35.95% in 2022. This return on equity is vital as it measures shareholder value creation; STM’s spike reflected leveraged growth without excessive dilution, as shares outstanding hovered stably around 900 million. Stock prices captured this euphoria: yearly highs hit $52.15 in 2021 and $55.85 in 2023, while lows remained resilient above $28-35 during peaks. PE ratios compressed dramatically to 8.09 in 2022 from 57.79 in 2016, indicating undervaluation at the top—investors piling in on forward earnings optimism.

Free cash flow per share, another cornerstone for sustainability, climbed to $6.63 in 2023 from $0.45 in 2016 (1,376% rise), supporting dividends and buybacks despite capex per share ballooning to -$5.01 (heavy investments in fabs). Notably, STM’s balance sheet strengthened, with shareholders’ equity swelling 266% to $17.68 billion by 2023, and net debt turning deeply negative at -$3.23 billion in 2024 (net cash position), providing a buffer against downturns.

The 2024 Downturn and Cyclical Pressures

The reversal in 2024 exposed vulnerabilities. Revenue plunged 23% year-over-year, gross margins eroded to 39.34% from 47.94% (-18% relative drop), and net income cratered 63% to $1.57 billion. EBT margin halved to 14.15%, while FCF per share flipped to -$0.23, with total FCF at -$211 million—the first negative reading since data begins. This correlates directly with capex moderation (from $4.53 billion to $3.18 billion, -30%) yet persistent working capital needs at $7.96 billion. ROIC tumbled to 7.25% from 21.04% in 2023, a red flag for capital allocation efficiency in semis, where high fixed costs amplify demand swings.

Stock price volatility intensified: 2024’s yearly low of $23.96 marked a multi-year trough, down sharply from 2023’s $35.20 low (-32%), though highs reached $49.05, hinting at intra-year rallies on AI hype. This divergence from fundamentals—PS ratio at 1.70 despite revenue contraction—suggests market hopes for recovery outpacing reality. Key events amplified this: the 2023-2024 inventory glut post-COVID, exacerbated by slower EV ramp-ups (STM derives ~30% revenue from auto chips), and US-China trade frictions curbing exports. STM’s 2021 auto chip crisis heroism—supplying shortage-hit OEMs—boosted its reputation, but 2024’s weak industrial demand (another core segment) bit back.

Geopolitically, Europe’s CHIPS Act and STM’s €5 billion Sicily fab expansion (announced 2024) aim to onshore production amid Taiwan risks, but ramp-up lags coincide with the downturn. Employee count dipped to 49,602 (-3.4% from 2023 peak), with revenue per employee falling 20% to €267,509, signaling underutilization.

Valuation Metrics in Context

Current valuations offer a mixed picture. PE expanded to 14.43 in 2024 from 10.38 in 2023, reasonable for a cyclical but elevated versus historical lows. PB ratio at 1.27 (near decade lows) screams value, as book value per share holds at $19.62 despite earnings pressure—important for assessing asset backing in tech. EV/Sales at 1.45 remains attractive versus 2021-22 peaks above 3.4, reflecting deleveraged enterprise value amid net cash.

Compared to stock evolution, 2024’s price action decoupled somewhat: despite profit halving, multiples didn’t collapse fully, buoyed by STM’s dividend yield (unstated but implied via FCF history) and sector rotation. Op cash flow halved to $2.97 billion (-50%), yet debt stable at $2.95 billion supports flexibility.

Analyst Forecasts and Future Trajectory

Looking ahead, analyst predictions paint a choppy recovery. Revenue is forecasted to dip further to $11.8 billion in 2025 (-11% from 2024) before rebounding to $9.52 billion in 2026—wait, no: data shows 2025 at $11.8B, 2026 at $9.52B? Headers go to 2028, but values sparse. Actually, 2025 revenue $11.8B (-11%), 2026 $9.52B (-19% further? No: 9520714285 ≈$9.52B for 2026? Predictions indicate prolonged softness, with EPS at $0.82 in 2026 (down from $1.73 2024) rising to $1.43 in 2027.

Gross margins may trough at 33.89% in 2025, signaling pricing pressures, but EBT rebounding to $400M implies stabilization. Net income projections: $739M in 2026, $1.22B 2027 (65% growth). Capex eases, aiding FCF recovery. ROE at 0.92% 2024 bottoms out, hinting at mean reversion.

Against the most recent close, analyst price targets imply modest upside: the mean target suggests ~3% potential gain, high end ~34% appreciation, while low end points to ~25% downside risk. This consensus reflects tempered optimism—AI tailwinds may favor hyperscalers over STM’s analog/power focus, but auto electrification (e.g., SiC chips) and EU subsidies could catalyze 2026-2028 upside. EV/Sales forecasts at 2.03 (2026?) warn of stretched multiples if growth falters.

Insider Activity and Market Signals

Insider transactions reveal a void: zero buys or sells across 2025-2026 months (Mar ’25-Feb ’26). This silence—unusual in volatile semis—may signal confidence in internal handling or caution amid uncertainty, lacking bullish reinforcement. No net selling pressure is positive, avoiding the dumps seen in prior peaks.

Macro and Sector Overlay

STM’s path intertwines with macro shifts. The 2018-2020 US-China trade war initially pressured, but STM’s diversified footprint (Europe/US/Asia) mitigated blows. Post-2022 inflation and Fed hikes crimped industrial capex, while 2024’s China slowdown hit consumer segments. Sector-wide, semis face inventory normalization into 2025, but STM’s 40%+ gross margins historically position it for rebound if auto cycles revive—GM strikes and EV slowdowns loom as risks.

Book value per share steady at ~$19.74 (2025 est.) and negative net debt provide resilience. If revenue per share recovers to $11.72 (2027), paired with 20%+ margins, EPS could exceed $2, justifying PE re-rating to 15-20x.

In sum, STM trades at a compelling inflection: post-peak digestion offers entry below historical averages, with forecasts eyeing gradual mending by 2027. Balance sheet fortress and strategic expansions counter cyclical woes, but execution amid geopolitics will dictate if it recaptures 2022 glory. Investors should monitor Q1 2026 prints for demand inflection.

(Word count: 1,128)

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us